KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verisign (VRSN) EBT (2016 - 2025)

Verisign (VRSN) has disclosed EBT for 17 consecutive years, with $271.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 9.27% year-over-year to $271.1 million, compared with a TTM value of $1.1 billion through Dec 2025, up 4.56%, and an annual FY2025 reading of $1.1 billion, up 4.56% over the prior year.
  • EBT was $271.1 million for Q4 2025 at Verisign, roughly flat from $271.7 million in the prior quarter.
  • Across five years, EBT topped out at $271.7 million in Q3 2025 and bottomed at $187.9 million in Q2 2021.
  • Average EBT over 5 years is $236.5 million, with a median of $245.3 million recorded in 2023.
  • The sharpest move saw EBT decreased 1.96% in 2021, then grew 16.39% in 2022.
  • Year by year, EBT stood at $203.4 million in 2021, then increased by 14.23% to $232.3 million in 2022, then rose by 8.31% to $251.6 million in 2023, then dropped by 1.39% to $248.1 million in 2024, then increased by 9.27% to $271.1 million in 2025.
  • Business Quant data shows EBT for VRSN at $271.1 million in Q4 2025, $271.7 million in Q3 2025, and $267.3 million in Q2 2025.